» Authors » Jing-Yuan Xu

Jing-Yuan Xu

Explore the profile of Jing-Yuan Xu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 83
Citations 572
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai X, Ling W, Cai X, Yan M, Zhang Y, Xu J
BMJ Open . 2025 Feb; 15(2):e086367. PMID: 39956601
Objectives: Sepsis-associated hypotension or shock is a critical stage of sepsis, and a current clinical emergency that has high mortality and multiple complications. A new restrictive fluid resuscitation therapy has...
2.
Li Z, Liu X, Tan F, Wang J, Qiao X, Feng Y, et al.
J Med Chem . 2025 Feb; 68(4):4352-4372. PMID: 39918588
Convincing evidence revealed that some platinum-based drugs could stimulate immunological recognition, thereby inducing immunogenic cell death (ICD). Indoleamine-2,3-dioxygenase (IDO) is overexpressed in tumors, which caused exhaustion of tryptophan (T-cell energy)...
3.
Hao Y, Wang Y, Zhou G, Zhao Y, Xu J, Chen X
Forensic Sci Int . 2025 Feb; 368:112388. PMID: 39913963
The examination of stamp impressions is a routine task for questioned document examiners (QDEs) in determining the authenticity of disputed documents. Some studies have provided methods for date determination of...
4.
Liu X, Li Z, Wang X, Ding B, Wang J, Qiao X, et al.
J Control Release . 2025 Jan; 379:797-813. PMID: 39848589
Platinum(II)-based antitumor drugs are widely used in clinics but limited by severe side effects and resistance. Multi-target Platinum(IV) complexes are emerging as ideal alternatives. Heme oxygenase-1 (HO-1) works as a...
5.
Ding B, Sang R, Li X, Fan J, Tian Y, Ma Y, et al.
Bioorg Chem . 2025 Jan; 154:108120. PMID: 39753041
As naturally essential biomacromolecule, HSA has become diagnostic indicators for various diseases and universal carriers for anticancer drug delivery, therefore, fluorescence detection and labeling for HSA possess significant application value...
6.
Gu S, Xu L, Sun W, Liang L, Lin L, Zou H, et al.
Int J Ophthalmol . 2024 Dec; 17(12):2177-2184. PMID: 39697895
Aim: To establish an animal model of form deprivation amblyopia based on a simulated cataract intraocular lens (IOLs). Methods: Poly(dimethyl siloxane)-SiO thin films (PSF) with different degrees of opacity as...
7.
Ma Z, Ding X, Zhu Z, Chen Q, Wang D, Qiao X, et al.
RSC Med Chem . 2024 Aug; PMID: 39185449
Colorectal cancer represents the over-expression of TMEM16A and COX-2, offering a promising therapeutic strategy. Two Pt(iv) conjugates derived from Pt(ii) drug (cisplatin or oxaliplatin) and niflumic acid, complexes 1 and...
8.
Jiang Z, Zhang Q, Wang Y, Liu Y, Zhao Y, Hao Y, et al.
Forensic Sci Int . 2024 Aug; 363:112186. PMID: 39127023
Printer source prediction is an important task when examining questioned documents. While some research has provided methods to predict the source printer of documents, with the advent of compatible consumables,...
9.
Zi S, Wu X, Tang Y, Liang Y, Liu X, Wang L, et al.
Adv Sci (Weinh) . 2024 Aug; 11(38):e2400647. PMID: 39119837
The development of acute respiratory distress syndrome (ARDS) in sepsis is associated with substantial morbidity and mortality. However, the molecular pathogenesis underlying sepsis-induced ARDS remains elusive. Neutrophil heterogeneity and dysfunction...
10.
Liu X, Zhu Z, He X, Zou Y, Chen Q, Wang X, et al.
ACS Appl Mater Interfaces . 2024 Jul; 16(31):40753-40766. PMID: 39046129
Platinum(II) drugs as a first-line anticancer reagent are limited by side effects and drug resistance. Stimuli-responsive nanosystems hold promise for precise spatiotemporal manipulation of drug delivery, with the aim to...